Comparative Medico-Economic Evaluation of Micrographic Mohs Surgery (MMS) and Traditional Surgical Excision With Immediate or Differed Reconstruction to Treat High Recurrence Risk Basal-Cell Carcinomas (BCC)
Inclusion Criteria:
- Age ≥ 18
- Histologically proved cutaneous BCC
- Categorized as "bad prognostic" according to the 2004 recommendations of ANAES
1. morpheaform or ill-limited clinical forms and histologically aggressive forms
(morpheaform, micronodular, infiltrating, squamous differentiation) OR
2. already recurred BCC (except for superficial BCCs) OR
3. nodular BCCs from the high-risk zone (nose and peri-orificial areas of the head)
and with diameter larger than 1 cm.
- Life expectancy greater than 3 years according to the investigator's opinion.
- Patient being informed and having signed the consent to participate to the study
Exclusion Criteria:
- History of X-ray therapy in the territory of the BCC
- Counter-indication to surgery
- Life expectancy < 3 years
- superficial BCCs, even if recurred
- Patient being unable to attend future follow-up visits
- Patient with severe cognitive impairment
- Patient not affiliated to a social security regimen